ConductScience.org, home

Paper24251858

Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Martiniano SL and 4 others. Ann Am Thorac Soc, 2014. Cited by 100 papers, by iCite.

Cite this record

ConductScience Library. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Papers, record 24251858. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24251858

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
PubMed
Journal
Ann Am Thorac Soc
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
100
iCite
Relative citation ratio, by iCite
4.22
iCite
Revised in PubMed
2021-10-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martiniano SLStacey L
2Sontag MKMarci K
3Daley CLCharles L
4Nick JAJerry A
5Sagel SDScott D

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Mycobacterium avium ComplexMajor topic
Mycobacterium avium-intracellulare InfectionMajor topic
Nontuberculous MycobacteriaMajor topic
Tuberculosis, PulmonaryMajor topic
Adolescent
Adult
Child
Cohort Studies
Coinfection
Female
Forced Expiratory Volume
Humans
Male
Mycobacterium Infections, Nontuberculous
Pseudomonas Infections
Pseudomonas aeruginosa
Retrospective Studies
Sputum
Young Adult

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 HL007670NHLBI NIH HHSUnited StatesT32HL007670PubMed and NIHNIH RePORTER
UL1 TR001082NCATS NIH HHSUnited StatesUL1TR001082PubMed and NIHNIH RePORTER
T32 HL007670-21NHLBI NIH HHSUnited StatesT32HL007670PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03312075Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.Background

Source ClinicalTrials.gov

Download CSV of trials

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119830845Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors.Pediatr Pulmonol2009https://conductscience.org/library/papers/19830845PubMed
220833823Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.Am J Respir Crit Care Med2011https://conductscience.org/library/papers/20833823PubMed
38131446Nontuberculous mycobacterial disease in adult cystic fibrosis patients.Chest1993https://conductscience.org/library/papers/8131446PubMed
417277290An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.Am J Respir Crit Care Med2007https://conductscience.org/library/papers/17277290PubMed
59659352Non-tuberculous mycobacteria in cystic fibrosis.Thorax1998https://conductscience.org/library/papers/9659352PubMed
612433669Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.Am J Respir Crit Care Med2003https://conductscience.org/library/papers/12433669PubMed
79872837Spirometric reference values from a sample of the general U.S. population.Am J Respir Crit Care Med1999https://conductscience.org/library/papers/9872837PubMed
821292659Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.Clin Infect Dis2011https://conductscience.org/library/papers/21292659PubMed
917145951Hypervirulence of a rough variant of the Mycobacterium abscessus type strain.Infect Immun2007https://conductscience.org/library/papers/17145951PubMed
1018378709Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18378709PubMed
1119846643Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.J Clin Microbiol2009https://conductscience.org/library/papers/19846643PubMed
1216000480Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis.J Clin Microbiol2005https://conductscience.org/library/papers/16000480PubMed
1312433668Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.Am J Respir Crit Care Med2003https://conductscience.org/library/papers/12433668PubMed
1414720400Mycobacterium abscessus and children with cystic fibrosis.Emerg Infect Dis2003https://conductscience.org/library/papers/14720400PubMed
1511303264Nontuberculous mycobacteria in patients with cystic fibrosis.Clin Infect Dis2001https://conductscience.org/library/papers/11303264PubMed
1611340540Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.Clin Infect Dis2001https://conductscience.org/library/papers/11340540PubMed
1715858802Nontuberculous mycobacterial infection in young children with cystic fibrosis.Pediatr Pulmonol2005https://conductscience.org/library/papers/15858802PubMed
1815684298Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.Eur Respir J2005https://conductscience.org/library/papers/15684298PubMed
1917693140Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.J Cyst Fibros2008https://conductscience.org/library/papers/17693140PubMed
2019467851Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs.Respir Med2009https://conductscience.org/library/papers/19467851PubMed

See all 39 referencesDownload CSV of references

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.

PMIDTitleJournalYearIn PapersSource
41007135The Epidemiology of Nontuberculous Mycobacteria in Cystic Fibrosis.Children (Basel)2025https://conductscience.org/library/papers/41007135PubMed
40957819Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI).J Cyst Fibros2026https://conductscience.org/library/papers/40957819PubMed
40744839Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections.Microbiol Spectr2025https://conductscience.org/library/papers/40744839PubMed
40171164Divergent host humoral innate immune response to the smooth-to-rough adaptation of Mycobacterium abscessus in chronic infection.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/40171164PubMed
40071337Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis.Ther Adv Respir Dis2025https://conductscience.org/library/papers/40071337PubMed
40063876
Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.
PLoS One2025https://conductscience.org/library/papers/40063876PubMed
39807497Epidemiology, microbiology and clinical impacts of non-tuberculous mycobacteria in adult patients with cystic fibrosis.Heliyon2025https://conductscience.org/library/papers/39807497PubMed
39413095Mycobacterium avium inhibits protein kinase C and MARCKS phosphorylation in human cystic fibrosis and non-cystic fibrosis cells.PLoS One2024https://conductscience.org/library/papers/39413095PubMed
38978544Genomic epidemiology of Mycobacterium abscessus at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission.ERJ Open Res2024https://conductscience.org/library/papers/38978544PubMed
38117792Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design.PLoS One2023https://conductscience.org/library/papers/38117792PubMed
38104098Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.Respir Res2023https://conductscience.org/library/papers/38104098PubMed
37666709Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.J Cyst Fibros2024https://conductscience.org/library/papers/37666709PubMed
37349306Mycobacterium abscessus VapC5 toxin potentiates evasion of antibiotic killing by ribosome overproduction and activation of multiple resistance pathways.Nat Commun2023https://conductscience.org/library/papers/37349306PubMed
37226498Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infections.Expert Opin Drug Discov2023https://conductscience.org/library/papers/37226498PubMed
36828670Phylogenomics of nontuberculous mycobacteria respiratory infections in people with cystic fibrosis.Paediatr Respir Rev2023https://conductscience.org/library/papers/36828670PubMed
36480571Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease.PLoS One2022https://conductscience.org/library/papers/36480571PubMed
36417800Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway.Tuberculosis (Edinb)2023https://conductscience.org/library/papers/36417800PubMed
36187967The AhR ligand phthiocol and vitamin K analogs as Pseudomonas aeruginosa quorum sensing inhibitors.Front Microbiol2022https://conductscience.org/library/papers/36187967PubMed
35905736Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance.Mol Cell2022https://conductscience.org/library/papers/35905736PubMed
35863022Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.Microbiol Spectr2022https://conductscience.org/library/papers/35863022PubMed

See all 54 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24251858

GET https://conductscience.org/api/papers/v1/24251858/references?page=2